Arvee Laboratories (India) Limited

NSE: ARVEE · Unclassified

₹227.46+5.00%06 Nov 2026

Check figures: unusual quarterly results in SEP '26 (₹2.56 cr vs a typical ₹0.21 cr). This may be a filing error (e.g. lakh filed as crore) or a genuine one-off; figures are shown as filed. Trailing-twelve-month figures include it.

Ask the data

Instant answers about Arvee Laboratories (India) Limited — computed from its filings, no language model

Market cap₹251 cr

Current price₹227.46

High / Low₹291 / ₹134

P/E38.0

P/B6.59

Book value₹34.5

ROE17.4%

ROCE21.0%

Debt / equity0.03

Dividend yield—

EPS (TTM)₹5.99

Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	47.4	40.3	62.5	30.4	38.5	31.5
EBITDA	6.0	5.7	8.4	3.0	3.6	3.2
Operating margin	12.7%	14.1%	13.5%	9.9%	9.4%	10.2%
Interest	0.6	0.4	0.4	0.2	0.2	0.2
Depreciation	2.4	2.3	2.1	1.5	1.1	1.2
Profit before tax	3.6	3.5	6.2	1.8	2.9	2.4
Tax	1.0	0.9	2.0	0.8	0.7	-0.1
Net profit	0.0	0.0	4.1	1.1	2.1	2.5
EPS ₹	2.43	2.34	3.74	0.95	1.95	2.29
Operating cash flow	—	4.0	2.4	6.7	-0.0	-0.1
Capex	—	0.0	1.5	2.6	1.9	2.8
Dividend paid	—	0.0	0.0	0.0	0.0	0.0
Total assets	—	—	38.7	38.6	38.2	43.3
Equity	—	—	28.1	29.1	31.3	33.8

Quarterly performance

last 22 quarters · ₹ crore

showing latest 8 of 22 periods

	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	8.8	9.1	10.7	7.9	12.7	18.2	22.7	16.2	12.6	7.6	7.7	6.1	10.6	12.5	8.9	6.5	7.5	3.5	9.8	10.8	17.2	24.9
Operating profit	1.1	1.4	1.7	1.0	1.5	2.3	3.3	1.7	1.2	1.0	0.5	0.8	1.5	1.5	0.3	0.2	0.3	0.1	1.6	1.1	2.5	3.4
Operating margin	11.9%	15.8%	15.8%	12.8%	12.2%	12.4%	14.3%	10.7%	9.2%	12.9%	6.8%	13.0%	14.5%	12.0%	3.9%	3.4%	4.5%	3.8%	16.6%	10.2%	14.5%	13.8%
Other income	0.3	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.2	0.3
Interest	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1
Depreciation	0.6	0.7	0.7	0.4	0.6	0.6	0.5	0.5	0.5	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3
Profit before tax	0.6	0.7	1.0	0.7	1.0	1.5	2.7	1.2	0.7	0.7	0.3	0.6	1.3	1.3	0.2	0.1	0.2	0.0	1.4	0.8	2.3	3.3
Tax	0.2	0.2	0.3	0.1	0.2	0.4	0.7	0.3	0.7	0.2	0.1	0.5	0.3	0.3	0.1	0.0	0.0	0.0	-0.4	0.3	0.6	0.8
Net profit	0.0	0.0	0.0	0.0	0.0	1.1	2.0	0.9	0.0	0.5	0.2	0.1	0.9	1.0	0.1	0.1	0.2	0.0	1.8	0.5	1.7	2.6
EPS ₹	0.39	0.48	0.66	0.48	0.71	1.03	1.86	0.84	0.01	0.44	0.22	0.11	0.85	0.89	0.14	0.06	0.15	0.01	1.66	0.47	1.54	2.32
Revenue YoY	—	—	—	—	43.2%	100.7%	112.5%	105.7%	-0.9%	-58.2%	-52.6%	-51.1%	39.5%	—	15.7%	5.0%	-29.4%	-72.5%	9.8%	67.4%	130.3%	622.6%
Profit YoY	—	—	—	—	—	—	—	—	—	-57.0%	-73.9%	1100.0%	91.8%	—	-37.5%	-41.7%	-81.9%	-99.0%	1120.0%	642.9%	894.1%	25500.0%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 16 periods

	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
ROE	—	—	—	11.8%	15.1%	14.7%	12.4%	7.3%	7.1%	6.8%	4.4%	1.3%	6.6%	7.5%	12.0%	17.4%
ROCE	—	—	—	18.9%	20.5%	22.5%	19.4%	11.5%	11.2%	9.7%	6.2%	2.1%	5.8%	7.6%	13.7%	21.0%
Net margin	0.0%	0.0%	2.3%	5.2%	5.9%	5.9%	5.9%	6.2%	5.7%	5.6%	3.9%	1.5%	7.7%	8.0%	9.8%	10.5%
EBITDA margin	14.2%	14.1%	13.1%	13.1%	12.6%	12.1%	12.1%	11.8%	11.0%	9.4%	6.8%	4.0%	8.5%	10.1%	13.0%	13.8%
Debt / equity	—	—	—	0.24	0.24	0.04	0.04	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03
Interest coverage	9.47	10.61	13.20	15.92	17.32	17.21	16.56	16.09	15.61	12.48	9.48	3.40	8.55	11.52	19.16	26.39
Asset turnover	—	—	—	1.37	1.55	1.80	1.53	0.92	0.95	1.01	0.93	0.65	0.67	0.73	0.95	1.03

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 8 periods

	SEP '22	MAR '23	MAR '24	SEP '24	MAR '25	SEP '25	MAR '26	SEP '26
Share capital	11.0	11.0	11.0	11.0	11.0	11.0	11.0	11.0
Other equity / reserves	16.1	17.0	18.1	20.0	20.2	20.4	22.8	27.0
Total equity	27.1	28.1	29.1	31.0	31.3	31.4	33.8	38.0
Borrowings	6.6	1.0	1.0	1.0	1.0	1.0	1.1	1.0
Current liabilities	16.7	9.1	7.3	6.9	4.6	6.8	7.5	20.2
Non-current liabilities	1.2	1.5	2.1	2.1	2.3	2.3	1.9	3.0
Total assets	45.0	38.7	38.6	40.0	38.2	40.6	43.3	61.2
Property, plant & equipment	13.0	12.7	12.7	13.0	15.3	15.2	16.7	16.4
Capital work-in-progress	1.0	1.5	2.6	2.8	0.7	0.8	0.9	0.9
Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Inventories	3.9	4.6	6.4	3.9	4.5	11.5	9.2	6.7
Receivables	16.9	12.3	6.1	9.8	8.4	2.4	10.4	22.4
Cash & equivalents	2.5	0.5	1.9	0.4	0.2	0.9	0.4	2.2

Cash flow

annual · ₹ crore · line = free cash flow

	FY22	FY23	FY24	FY25	FY26
Cash from operations	4.0	2.4	6.7	-0.0	-0.1
Cash from investing	0.1	-1.3	-5.2	-1.4	0.5
Cash from financing	-6.0	-2.5	-0.2	-0.2	-0.2
Capex	0.0	1.5	2.6	1.9	2.8
Free cash flow	4.0	0.9	4.1	-1.9	-3.0
Dividends paid	0.0	0.0	0.0	0.0	0.0

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹16.4 cr27%

CWIP

₹0.9 cr1%

Inventories

₹6.7 cr11%

Receivables

₹22.4 cr37%

Cash & equivalents

₹2.2 cr4%

Other assets

₹12.7 cr21%

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
Arvee Laboratories (India) Limited	251	227.46	38.0	6.59	17.4%

StoxGud checklist: Bullish setup · 9/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month+7.4%

6 months+35.9%

1 year+38.7%

3Y CAGR+25.4%

5Y CAGR+25.6%

10Y CAGR—

50-day avg₹198.93

200-day avg₹170.22

RSI (14)51

FAQs

What is the share price of Arvee Laboratories (India) Limited?

Arvee Laboratories (India) Limited (ARVEE) closed at ₹227.46 on NSE on 06 Nov 2026.

What is the market cap of Arvee Laboratories (India) Limited?

₹251 crore at the latest close.

What is the P/E ratio of Arvee Laboratories (India) Limited?

38.0, on trailing-twelve-month earnings from its filings.

How fast is Arvee Laboratories (India) Limited growing?

Arvee Laboratories (India) Limited: revenue has compounded at -20.4% a year over three years; net profit at -15.0% a year. Latest-quarter revenue is up 622.6% year on year, profit up 25,500.0%.

How profitable is Arvee Laboratories (India) Limited?

On a trailing-twelve-month basis return on equity is 17.4%, return on capital employed 21.0%, operating margin 13.8%, net margin 10.5%.

How much debt does Arvee Laboratories (India) Limited have?

Arvee Laboratories (India) Limited is debt-free: debt to equity is 0.03 with borrowings of ₹1 cr against cash of ₹2 cr (balance sheet of 2026-09-30). Operating profit covers interest 26.4 times.

Financials parsed from Arvee Laboratories (India) Limited's own XBRL filings to NSE (standalone), ₹ crore unless marked. Quarterly from MAR '21, annual from FY21, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.